Image: Shutterstock/anyaivanova Image: Shutterstock/anyaivanova IRISH BIOTECH COMPANY Inflazome has been acquired by Swiss drug giant Roche for €380 million.
It is understood that they are also eligible to receive additional payments contingent on the achievement of certain milestones. Speaking on the Pat Kenny Show on Newstalk this morning, Professor O’Neill said, “Roche can now take our drug and bring it to the clinic, which is tremendously exciting. Founded in 2016, the company’s intellectual property is based on the Science Foundation Ireland-funded research of Professor O’Neill at Trinity College Dublin in partnership with the University of Queensland.
لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر: